Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 16714-176

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 16714-176). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 01)

A line graph comparing cumulative incidence percentages over time (0 to 3.5 years) between Atorvastatin and placebo groups. The solid line represents Atorvastatin, showing a lower cumulative incidence than the dashed placebo line. The graph includes a hazard ratio (HR=0.64) with confidence intervals and a p-value.*

FDA Label Image

Figure-02 (Figure 02)

A line graph showing cumulative hazard (%) over time in years (up to 5 years) comparing Atorvastatin and placebo. The graph illustrates time to first primary endpoint through four years of follow-up, with Atorvastatin showing a lower cumulative hazard than placebo. The hazard ratio (HR) is 0.63 with a p-value of 0.001.*

FDA Label Image

Figure-03 (Figure 03)

A line chart comparing the percentage of subjects experiencing a major cardiovascular event over time between Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis represents time in years to the first major cardiovascular endpoint, up to 5 years, while the y-axis indicates the percentage of subjects experiencing the event. The chart includes a hazard ratio (HR) of 0.78 with a confidence interval of 0.69-0.89 and a p-value of 0.0002 comparing the two dosages.*

FDA Label Image

Btl-lbl-10mg-90s.jpg (Btl Lbl 10mg 90s)

Label for Atorvastatin Calcium Tablets, USP 10 mg, manufactured by Northstar Rx LLC. The label indicates a package of 90 film-coated tablets with storage instructions and manufacturer details, including Apotex Inc. in Toronto, Canada. It includes an NDC number 16714-173-01 and dosage information.*

FDA Label Image

Btl-lbl-20mg-90s.jpg (Btl Lbl 20mg 90s)

Label for Atorvastatin Calcium Tablets, USP 20 mg by Northstar Rx LLC, showing a package of 90 tablets. The label includes storage instructions, dosage reference, manufacturer information, and a barcode. The product is Rx only and features clear branding and dosage strength on a blue and white background.*

FDA Label Image

Btl-lbl-40mg-90s.jpg (Btl Lbl 40mg 90s)

Label for Atorvastatin Calcium Tablets, USP 40 mg by NorthStar Rx LLC. The bottle contains 90 film-coated tablets. The label includes storage instructions, manufacturing information for NorthStar Rx LLC and Apotex Inc., and contact information for medication guides.*

FDA Label Image

Btl-lbl-80mg-90s.jpg (Btl Lbl 80mg 90s)

Atorvastatin Calcium Tablets, USP 80 mg film-coated tablets label showing 90 tablets in the package. The label includes the NDC 16714-176-01, manufacturer Northstar Rx LLC, and additional manufacturing information for Apotex Inc. It also provides storage instructions and a contact number for medication guides.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of atorvastatin calcium, showing the molecular configuration of its components, including calcium ions and atorvastatin moieties, as typically represented in pharmaceutical labeling for this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.